What Is Inflammaging? The Molecular Roots of Chronic Inflammation
Inflammaging is not an accident of aging — it is mechanistically upstream of it. The term, coined by immunologist Claudio Franceschi in 2000, describes a state of chronic, low-grade, sterile (no pathogen) systemic inflammation that rises progressively with age and is now recognized as a key driver behind cardiovascular disease, neurodegeneration, metabolic syndrome, sarcopenia, and cancer.
Unlike the acute inflammation that heals a cut or clears an infection — which spikes and resolves within days — inflammaging smolders. Cytokine levels remain modestly but persistently elevated for years, decades. The immune system is perpetually half-activated. This is biologically costly in four compounding ways.
1. Senescent Cells and the SASP
As cells accumulate DNA damage, mitochondrial dysfunction, or reach their replicative limit, they enter senescence — a state where they stop dividing but refuse to die. Senescent cells are not inert. They actively secrete a cocktail of pro-inflammatory cytokines, chemokines, and proteases known as the Senescence-Associated Secretory Phenotype (SASP): IL-1α, IL-6, IL-8, TNF-α, MMP-3, and dozens more. The SASP poisons neighboring cells, degrades extracellular matrix, and recruits immune cells that perpetuate the cycle. As senescent cell burden grows with age, so does systemic inflammation.
2. Mitochondrial DNA Leakage
Mitochondria carry their own circular DNA (mtDNA), a molecular relic of their bacterial ancestry. When mitochondria are damaged — by reactive oxygen species, mechanical stress, or metabolic excess — they can release mtDNA fragments into the cytoplasm and circulation. Because mtDNA is structurally similar to bacterial DNA, the innate immune system reads it as a pathogen signal via STING and cGAS pathways, triggering a sterile inflammatory response. This is one reason that mitochondrial health is so intimately linked to systemic inflammation biomarkers.
3. Microbiome Dysbiosis
The gut microbiome changes substantially with age: diversity decreases, beneficial commensals (Bifidobacterium, Akkermansia muciniphila, Faecalibacterium prausnitzii) decline, and proinflammatory bacteria increase. Simultaneously, intestinal barrier integrity weakens — "leaky gut" allows lipopolysaccharide (LPS), a bacterial cell-wall component, to translocate into the bloodstream. LPS is a potent NF-κB activator. Elevated plasma LPS — sometimes called "metabolic endotoxemia" — has been measured in obese, diabetic, and aging individuals and correlates strongly with inflammatory biomarkers.
4. Chronic NF-κB Activation
NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) is the master transcription factor of inflammation. Under normal circumstances it is tightly regulated — activated by a threat (injury, infection, oxidative stress), then switched off. In aging tissue, the combination of SASP cytokines, mtDNA leakage, LPS, and persistent reactive oxygen species keeps NF-κB constitutively active. This sustains production of IL-6, TNF-α, COX-2, and other inflammatory mediators. Crucially, NF-κB itself promotes senescence while being driven by senescent cells — a vicious feed-forward loop that accelerates biological aging independent of chronological time.
The key insight: Inflammaging is a system-level failure, not a single pathway. Senescent cells, damaged mitochondria, a dysbiotic gut, and chronically active NF-κB form a self-reinforcing loop that is measurable — and partially modifiable — through biomarkers and targeted lifestyle interventions.
Key Inflammation Biomarkers: What to Measure and Optimal Ranges
Tracking inflammation requires moving beyond standard cholesterol panels. The following biomarkers form a practical inflammaging panel — most are available through standard blood work or direct-to-consumer labs (Quest, LabCorp, Function Health).
High-Sensitivity C-Reactive Protein (hsCRP)
The most widely used inflammation marker. CRP is produced by the liver in response to IL-6 signals. The high-sensitivity assay detects low-level chronic inflammation that standard CRP tests miss. AHA/CDC risk stratification: <1 mg/L = low risk, 1–3 mg/L = moderate, >3 mg/L = high. For longevity purposes, aim below 0.5 mg/L. Elevated hsCRP predicts cardiovascular events, stroke, diabetes, and all-cause mortality. Important caveat: hsCRP rises sharply with any acute infection or injury — always retest at least 2 weeks after illness.
Interleukin-6 (IL-6)
A primary driver of the acute-phase response that stimulates hepatic CRP production. IL-6 is secreted by macrophages, adipose tissue, senescent cells (as part of SASP), and — transiently — contracting muscle. Chronically elevated IL-6 (>3.5 pg/mL) in older adults predicts disability, frailty, cognitive decline, and all-cause mortality. Harris et al. (1999) showed IL-6 predicted mortality better than cholesterol in a cohort of 70–79 year-olds. Optimal range: <1.8 pg/mL. Note: IL-6 is expensive to test and less standardized than hsCRP — use it alongside hsCRP for a fuller picture.
Tumor Necrosis Factor-Alpha (TNF-α)
A potent pro-inflammatory cytokine secreted by macrophages and adipocytes. TNF-α drives insulin resistance, muscle catabolism (sarcopenia), and neuroinflammation. It directly activates NF-κB, creating the feedback loop described above. Reference range: <8.1 pg/mL. Chronically elevated TNF-α is observed in obesity, rheumatoid arthritis, and neurodegenerative conditions. Anti-TNF biologics (etanercept, adalimumab) are among the most successful drugs in inflammatory disease — demonstrating how central TNF-α is to pathological inflammation.
Fibrinogen
A blood-clotting protein and acute-phase reactant. Elevated fibrinogen reflects hepatic inflammation and predicts cardiovascular events independently of LDL cholesterol. Optimal: 200–350 mg/dL. Values above 450 mg/dL indicate significant inflammatory burden. Fibrinogen is part of the Framingham Risk Score extended to include inflammatory markers and is particularly valuable as a cardiovascular risk assessment tool when combined with hsCRP.
Ferritin
Primarily an iron-storage protein, ferritin is also an acute-phase reactant — it rises with inflammation independent of iron status. Chronically elevated ferritin (>200 ng/mL in women, >300 ng/mL in men, in the absence of iron-deficiency anemia treatment) is associated with metabolic syndrome, NAFLD, and increased oxidative stress. For longevity assessment, ferritin in the 50–100 ng/mL range appears optimal. Very low ferritin (<25 ng/mL) signals iron deficiency; very high signals inflammatory or iron-overload pathology.
White Blood Cell Count (WBC)
A simple, inexpensive proxy for immune activation. A high-normal WBC count (above 7,000 cells/μL) in otherwise healthy adults is independently associated with cardiovascular risk and shorter telomere length. Optimal: 4,500–6,000 cells/μL. The WBC differential (neutrophil-to-lymphocyte ratio, NLR) adds further nuance: NLR >2.5 in healthy adults is associated with increased systemic inflammation and adverse metabolic outcomes.
Practical tip: A basic inflammaging panel (hsCRP, ferritin, complete blood count) can be ordered at most standard labs for under $50 and interpreted without specialist referral. Add IL-6 and fibrinogen every 1–2 years for a complete picture. Track trends over time, not single readings.
Diet as Anti-Inflammatory Tool: The Evidence
Diet is the highest-leverage modifiable variable in inflammaging. The inflammatory potential of a diet is quantified by indices like the Dietary Inflammatory Index (DII) — scores from the most anti-inflammatory (−8.87) to most pro-inflammatory (+7.98), validated across 45 countries.
The Mediterranean Diet: Gold-Standard Evidence
The PREDIMED trial (Prevención con Dieta Mediterránea, n=7,447) remains the landmark RCT. Participants randomized to a Mediterranean diet supplemented with extra-virgin olive oil (EVOO) or mixed nuts showed a 30% reduction in major cardiovascular events over 4.8 years compared to a low-fat control diet. Mechanistically, the Mediterranean diet reduced plasma IL-6, CRP, and IL-18. The PREDIMED-Plus follow-up confirmed sustained reductions in hsCRP and improved metabolic parameters. Core components: abundant olive oil, vegetables, legumes, whole grains, fish, moderate red wine, and minimal red/processed meat.
Omega-6:Omega-3 Ratio
Modern Western diets carry an omega-6:omega-3 ratio of approximately 15–20:1, versus the estimated ancestral ratio of 4:1. Omega-6 fatty acids (arachidonic acid from linoleic acid) are precursors to pro-inflammatory eicosanoids (PGE2, LTB4). Omega-3 fatty acids (EPA and DHA from oily fish; ALA from flaxseed) compete for the same enzymatic pathways, displacing arachidonic acid and producing resolvins and protectins — specialized pro-resolving mediators (SPMs) that actively switch off inflammation. Reducing dietary omega-6 (seed oils) while increasing omega-3 consistently lowers hsCRP and IL-6 across intervention studies. Target ratio: 4:1 or lower.
Ultra-Processed Foods and Inflammatory Load
A 2022 analysis of the UK Biobank (n=117,366) found each additional serving of ultra-processed food (UPF) per day associated with a 4.3% increase in hsCRP and measurably elevated IL-6. UPFs (defined by the NOVA classification as industrially manufactured products containing additives absent from home cooking) drive inflammation through multiple pathways: high refined carbohydrate load triggers glycation and AGE formation; emulsifiers (carboxymethylcellulose, polysorbate-80) directly disrupt gut barrier integrity; high omega-6 vegetable oil content shifts the pro/anti-inflammatory ratio. Every UPF serving removed is measurably anti-inflammatory.
Dietary priority stack: (1) Increase EVOO and oily fish; (2) Replace seed oils with olive oil; (3) Add daily leafy greens, berries, and legumes; (4) Reduce ultra-processed food to fewer than 3 servings per week. This alone can move hsCRP from the high-risk (>3 mg/L) to the low-risk (<1 mg/L) zone within 3–6 months in compliant individuals.
Lifestyle Anti-Inflammatories: Exercise, Sleep, and Stress
Exercise: The IL-6 Paradox
Exercise presents a fascinating immunological paradox. During acute exercise, contracting skeletal muscle produces large amounts of IL-6 — sometimes 10–100x resting levels. Yet regular exercisers have chronically lower systemic IL-6 and hsCRP. The resolution: muscle-derived IL-6 (myokine IL-6) behaves differently from adipose- or macrophage-derived IL-6. Myokine IL-6 promotes glucose uptake, fat oxidation, and downstream anti-inflammatory cytokines (IL-10, IL-1Ra), while inhibiting TNF-α. Epidemiological data consistently show 150 min/week of moderate aerobic exercise reducing hsCRP by 20–35% and being one of the most powerful non-pharmacological anti-inflammatory interventions available.
Resistance training adds distinct benefits: muscle mass directly competes with adipose tissue for energy substrate, and skeletal muscle is the largest glucose-consuming organ — reducing postprandial blood glucose spikes that drive glycation and NF-κB activation. Even a single bout of moderate exercise acutely suppresses NF-κB nuclear translocation in peripheral blood mononuclear cells for up to 24 hours.
Sleep Deprivation and Inflammatory Signaling
Sleep is the most underestimated anti-inflammatory intervention. A landmark experimental study (Irwin et al., 2016) demonstrated that just one night of partial sleep loss (4 hours) was sufficient to activate NF-κB in monocytes to the same degree as a low-dose lipopolysaccharide injection. Chronic sleep restriction (6 hours/night for 2 weeks) raises plasma IL-6 by ~40% and TNF-α by ~25% compared to 8-hour sleep. The mechanisms involve cortisol-driven immune suppression loss, sympathetic nervous system activation elevating norepinephrine (which activates NF-κB), and disrupted circadian regulation of cytokine gene expression. Optimizing sleep is not optional for inflammaging management — it is foundational.
Stress and Cortisol-Driven Chronic Inflammation
The relationship between psychological stress and inflammation is mediated by the HPA (hypothalamic-pituitary-adrenal) axis. Acute stress elevates cortisol, which is acutely anti-inflammatory. Paradoxically, chronic psychological stress leads to glucocorticoid resistance — immune cells downregulate cortisol receptors, blunting the cortisol-mediated anti-inflammatory brake. The result: stressed individuals show elevated IL-6, IL-1β, and CRP despite normal or even elevated cortisol levels. Kiecolt-Glaser et al. (2003) showed caregivers of Alzheimer's patients (a chronic stress model) had significantly higher IL-6 levels and slower wound healing than age-matched controls. Interventions shown to lower inflammatory markers: mindfulness-based stress reduction (MBSR), 8 weeks reducing hsCRP by ~15%, and social connection (loneliness raises IL-6 comparably to smoking).
Targeted Supplements: Evidence, Dosing, and Quality
Supplements are the third layer of an anti-inflammaging protocol — effective adjuncts when diet and lifestyle are already optimized, not substitutes for them. The following have the strongest clinical evidence.
Omega-3 Fatty Acids (EPA + DHA)
The most extensively studied anti-inflammatory supplement. Paul Calder's 2017 review in Annals of Nutrition & Metabolism synthesized over 100 RCTs: omega-3 supplementation consistently reduces plasma triglycerides, hsCRP, IL-6, TNF-α, and IL-1β. Dose matters — the anti-inflammatory threshold appears to be 2–4g combined EPA+DHA daily, with higher doses needed for established inflammatory conditions. The REDUCE-IT trial (4g/day icosapentaenoic acid) showed 25% reduction in cardiovascular events in statin-treated patients with elevated triglycerides. Form matters too: triglyceride-form fish oil has 70% superior absorption to ethyl ester form. Look for products that third-party test for rancidity (TOTOX value <26).
Curcumin + Piperine (Bioperine)
Curcumin, the active polyphenol in turmeric, directly inhibits NF-κB nuclear translocation and downstream COX-2 and iNOS enzyme activity — in vitro and in animal models, the anti-inflammatory effects are potent. Human bioavailability has historically been the limiting factor: standard curcumin is poorly absorbed from the gut. The addition of piperine (from black pepper extract, 5–20 mg) increases curcumin bioavailability by 2,000% by inhibiting hepatic glucuronidation. Enhanced-absorption formulations (phospholipid complexes, nanoparticle encapsulation, BCM-95, Meriva) further improve delivery. A 2016 meta-analysis (Sahebkar) of 8 RCTs found curcumin supplementation significantly reduced plasma CRP, IL-6, and MDA (oxidative stress marker). Effective dosing: 500–1,500 mg curcuminoids daily with piperine.
Resveratrol
A polyphenol found in red grape skins, resveratrol activates SIRT1 (the longevity-associated deacetylase), inhibits NF-κB, and reduces SASP factor secretion from senescent cells in vitro. Human evidence is more mixed than the animal data suggested — bioavailability is low (approximately 1% for free resveratrol), and the positive signals seen in Sinclair lab studies have not consistently replicated in human RCTs at standard doses. However, trans-resveratrol at 500–1,000 mg/day has shown modest reductions in IL-6 and CRP in overweight and diabetic populations. It remains a reasonable adjunct but is lower priority than omega-3 and curcumin. Evidence grade: Moderate (human RCT data mixed).
Quercetin
A flavonoid with dual anti-inflammatory and senolytic (senescent-cell-clearing) properties. Quercetin inhibits PI3K/Akt and NF-κB signaling and, in combination with dasatinib (a prescription tyrosine kinase inhibitor), has shown senolytic activity in human pilot studies (Justice et al., 2019 — MAYO Clinic). Standalone quercetin at 500–1,000 mg/day reduces plasma IL-6, TNF-α, and CRP in several RCTs. Bioavailability is enhanced by fat co-ingestion and phytosome formulations (Quercefit). It combines well with curcumin and may potentiate curcumin's anti-inflammatory effects. Evidence grade: Moderate-to-high for anti-inflammatory; Preliminary for senolytic effects in humans.
Evidence Summary: Anti-Inflammatory Interventions
| Intervention | Primary Mechanism | Biomarker Impact | Key Study | Evidence Grade |
|---|---|---|---|---|
| Mediterranean Diet | Polyphenols, EVOO oleocanthal (COX inhibitor), fiber → gut microbiome | hsCRP ↓25–35%, IL-6 ↓, cardiovascular events ↓30% | PREDIMED RCT, n=7,447 (Estruch et al., 2013) | HIGH |
| Omega-3 EPA+DHA (≥2g/day) | Displaces arachidonic acid; generates resolvins/protectins; suppresses NF-κB | hsCRP ↓, IL-6 ↓, TNF-α ↓, TG ↓20–30% | Calder 2017 meta-analysis; REDUCE-IT 2018 (n=8,179) | HIGH |
| Aerobic Exercise (150 min/wk) | Myokine IL-6 → IL-10 / IL-1Ra; reduces adipose inflammation; glucose disposal | hsCRP ↓20–35%, IL-6 (chronic) ↓, NF-κB activation ↓ | Kasapis & Thompson 2005 meta-analysis; Petersen & Pedersen 2005 | HIGH |
| Curcumin + Piperine | Direct NF-κB inhibition; COX-2 / iNOS suppression; AP-1 inhibition | CRP ↓, IL-6 ↓, MDA ↓ (8 RCTs, Sahebkar 2016 meta-analysis) | Sahebkar et al. 2016 meta-analysis (8 RCTs) | MODERATE |
| Sleep Optimization (7–9 hrs) | Circadian cytokine regulation; cortisol receptor sensitivity restoration; NF-κB suppression | IL-6 ↓40%, TNF-α ↓25% vs. chronic restriction; NF-κB activation ↓ | Irwin et al. 2016; Spiegel et al. 2002 | HIGH |
The 8-Step Anti-Inflammaging Protocol
Order hsCRP, ferritin, CBC with differential, and fasting glucose. Add IL-6 and fibrinogen if available. Retest every 6 months while making changes to quantify progress.
Replace seed oils with extra-virgin olive oil. Eat oily fish (salmon, sardines, mackerel) at least 3×/week. Add leafy greens, berries, and legumes daily. Reduce ultra-processed food to <3 servings/week.
Supplement 2–4g combined EPA+DHA daily (triglyceride-form, TOTOX <26). This is the single highest-evidence supplement intervention for systemic inflammation.
Brisk walking, cycling, swimming at a pace where you can speak in sentences. Add 2 sessions of resistance training per week to preserve muscle mass and improve glucose disposal.
Consistent sleep/wake schedule. Room temperature 65–67°F. No alcohol within 3 hours of bed (alcohol fragments sleep architecture and acutely raises IL-6). Treat sleep apnea — it is a major inflammation amplifier.
Implement one consistent stress-reduction practice: 20 minutes of mindfulness meditation daily, cold exposure (3× weekly), or yoga. Avoid chronic social isolation — loneliness raises IL-6 to a comparable degree as 15 cigarettes/day.
500–1,000mg curcuminoids with 5–10mg piperine with meals. Add 500mg quercetin (phytosome form preferred). These adjuncts add NF-κB inhibition on top of dietary and lifestyle foundations.
Increase dietary fiber to 30–40g/day (feeds Bifidobacterium and Faecalibacterium prausnitzii). Include fermented foods (kefir, kimchi, sauerkraut) — a 2021 Stanford RCT showed they increased microbiome diversity and decreased inflammatory markers more than a high-fiber diet alone.
Continue Your Research
Inflammaging sits at the intersection of multiple longevity pathways. Explore the connected science below.